Clinical Trial Update: Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis [Phase 2]

View source ↗

Summary

Phase II trial results for the gamma-secretase inhibitor PF-03084014 in adults with desmoid tumors/aggressive fibromatosis have been completed and results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive Fibromatosis
• Desmoid Tumors

Drugs mentioned

• PF-03084014 (nirogacestat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Desmoid Tumors, Aggressive Fibromatosis | Phase 2 | Status: COMPLETED | Results posted: 2020-02-05